Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-27 Sale |
2021-08-27 4:55 pm |
Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer |
33,779 | $60.12 | $2,030,864 | 263,340 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-19 4:30 pm |
Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer |
54,000 | $50.37 | $2,720,182 | 297,119 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-08-27 Exercise |
2021-08-27 4:55 pm |
N/A 2030-08-19 |
Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer |
33,779 | $0 | 263,340 (Direct) |
View |
| 2021-08-27 Exercise |
2021-08-27 4:55 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer |
33,779 | $20 | 263,340 (Direct) |
View |
| 2021-08-17 Exercise |
2021-08-19 4:30 pm |
N/A 2030-08-19 |
Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer |
54,000 | $0 | 297,119 (Direct) |
View |
| 2021-08-17 Exercise |
2021-08-19 4:30 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer |
54,000 | $20 | 297,119 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 4:52 pm |
N/A 2031-02-28 |
Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2020-08-20 Option Award |
2020-08-21 6:28 pm |
N/A 2030-08-19 |
Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer |
351,119 | $0 | 351,119 (Direct) |
View |